IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The company is headquartered in Dartmouth, Nova Scotia and currently employs 63 full-time employees. The company went IPO on 2018-06-01. The firm has sold all of its assets. The company is not engaged in any business operations.
9명의 애널리스트가 IMVIF에 대해 제공한 주식 평가를 기반으로 Feb 01, 2024에 업데이트됨
Strong Buy
Strong buy
3
Buy
5
Hold
1
Sell
0
Strong sell
0
Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for IMVIF. Our analysts highlight strong fundamentals and favorable market sentiment, positioning IMVIF for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: IMVIF is a Strong Buy candidate.
IMVIF stock price ended at $0 on 수요일, after rising NaN%
On the latest trading day Dec 24, 2025, the stock price of IMVIF rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 29.1K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 1.8K shares were traded, amounting to a market value of approximately --.
IMVIF 기술적 시그널
기술적 시그널 요약
구매 신호 2
중립 신호 4
매도 신호 1
Strong Sell
Sell
Neutral
Buy
Strong Buy
IMVIF은 현재 2개의 매수 신호와 1개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 상승 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 --입니다. 전반적으로 기술적 지표들은 중기적으로 Buy 전망을 나타내고 있습니다.
IMVIF에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 IMVIF 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.